30year

  1. T

    Sihuan Pharmaceutical Obtains 30-Year Exclusive Distribution Rights For One Of The Be

    Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460), a leading pharmaceutical company with the largest cardio-cerebral vascular drug franchise in China by market share, today announced that its wholly-owned subsidiary Hainan Sihuan Pharmaceutical Co., Ltd. has entered a distributorship...
  2. T

    Smith & Nephew Receives FDA 510k Clearance For A 30-year Knee

    As evidence of its drive to return knee pain sufferers to a lifetime of physical activity, Smith & Nephew ( SNN, LSE: SN) Orthopaedics Division announces the results of unprecedented testing on its VERILAST technology for knee replacement implants. After simulating 30 years of physical activity...
Back
Top